Literature DB >> 11251928

Pena-Shokeir phenotype with variable onset in three consecutive pregnancies.

D Paladini1, A Tartaglione, A Agangi, S Foglia, P Martinelli, C Nappi.   

Abstract

The Pena-Shokeir phenotype represents an autosomal recessive syndrome characterized by neurogenic arthrogryposis, facial anomalies and pulmonary hypoplasia. Prenatal diagnosis of this disease has been reported prospectively and in cases with positive family history. We describe here a patient who has had three consecutive pregnancies affected by the Pena-Shokeir syndrome. In these pregnancies, the onset of the arthrogryposis varied between the 12th and the 18th week of gestation. Therefore, the possibility of a variable chronological development of the main diagnostic feature of the syndrome, arthrogryposis, has to be taken into proper consideration while counseling families with a positive history for the Pena-Shokeir phenotype.

Entities:  

Mesh:

Year:  2001        PMID: 11251928     DOI: 10.1046/j.1469-0705.2001.00246.x

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  4 in total

1.  Antenatal ultrasonography findings and magnetic resonance imaging in a case of Pena-Shokeir phenotype.

Authors:  Xuan-Hong Tomai; Thanh-Xuan Jasmine; Thanh-Hai Phan
Journal:  Ultrasound       Date:  2017-01-10

2.  Prenatal Diagnosis of Arthrogryposis as a Phenotype of Pena-Shokeir Syndrome using Two- and Three-dimensional Ultrasonography.

Authors:  Eduardo Felix Martins Santana; Priscila Nogueira Oliveira Serni; Liliam Cristine Rolo; E Araujo Júnior
Journal:  J Clin Imaging Sci       Date:  2014-04-29

Review 3.  Pena-Shokeir syndrome: current management strategies and palliative care.

Authors:  Sumaiya Adam; Melantha Coetzee; Engela Magdalena Honey
Journal:  Appl Clin Genet       Date:  2018-10-25

4.  Prognostic significance of prenatal ultrasound in fetal arthrogryposis multiplex congenita.

Authors:  Brit Busack; Claus-Eric Ott; Wolfgang Henrich; Stefan Verlohren
Journal:  Arch Gynecol Obstet       Date:  2020-10-22       Impact factor: 2.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.